The Dominantly Inherited Alzheimer Network (DIAN), Core B: Clinical is responsible for the protocol development of all clinical operations for the research studies, including participant recruitment, enrollment and protection;performing clinical evaluations including neuropsychometric testing, completing imaging, blood and CSF collections, and offering genetic counseling and testing. The study of dominantly inherited Alzheimer Disease will likely lead to a better understanding of the causes of Alzheimer Disease and potential methods of detecting it at the earliest stages, even before clinical symptoms have begun. This will allow for preventative treatments to be tested. The clinical core will obtain highly sensitive clinical evaluations and neuropsychometric testing to determine the earliest symptoms and progression rates. The clinical core will also obtain imaging studies, blood and cerebral-spinal fluid to measure biomarker changes which may occur before symptoms. The data generated from these studies will be used by DIAN investigators to advance the understanding of the causes of Alzheimer Disease, methods of early detection, and design future preventative treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AG032438-06
Application #
8600216
Study Section
Special Emphasis Panel (ZAG1-ZIJ-1)
Project Start
Project End
Budget Start
2014-01-01
Budget End
2014-12-31
Support Year
6
Fiscal Year
2014
Total Cost
$165,294
Indirect Cost
$57,652
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Su, Yi; Blazey, Tyler M; Snyder, Abraham Z et al. (2015) Partial volume correction in quantitative amyloid imaging. Neuroimage 107:55-64
Fagan, Anne M; Xiong, Chengjie; Jasielec, Mateusz S et al. (2014) Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Sci Transl Med 6:226ra30
Xiong, Chengjie; Luo, Jingqin; Gao, Feng et al. (2014) Optimizing parameters in clinical trials with a randomized start or withdrawal design. Comput Stat Data Anal 69:101-113
Brier, Matthew R; Thomas, Jewell B; Snyder, Abraham Z et al. (2014) Unrecognized preclinical Alzheimer disease confounds rs-fcMRI studies of normal aging. Neurology 83:1613-9
Xiong, Chengjie; Weng, Hua; Bennett, David A et al. (2014) Subsets of a large cognitive battery better power clinical trials on early stage Alzheimer's disease. Neuroepidemiology 43:131-9
Storandt, Martha; Balota, David A; Aschenbrenner, Andrew J et al. (2014) Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). Neuropsychology 28:19-29
Ting, Simon Kang Seng; Benzinger, Tammie; Kepe, Vladimir et al. (2014) A novel PSEN1 mutation (I238M) associated with early-onset Alzheimer's disease in an African-American woman. J Alzheimers Dis 40:271-5
Gordon, Brian A; Blazey, Tyler; Benzinger, Tammie Ls (2014) Regional variability in Alzheimer's disease biomarkers. Future Neurol 9:131-134
Ryman, Davis C; Acosta-Baena, Natalia; Aisen, Paul S et al. (2014) Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology 83:253-60
Dobrowolska, Justyna A; Kasten, Tom; Huang, Yafei et al. (2014) Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system. PLoS One 9:e89998

Showing the most recent 10 out of 20 publications